Avoiding fatty, spicy, or heavily seasoned foods during the initial treatment period can also minimise gastrointestinal upset
IB, LF, JB, RG, and IS reviewed the scientific content
The manufacturer recommends discontinuing treatment if a patient is unable to tolerate the 2.4-mg dose
however, it was accompanied by significant weight gain ( 4.1.3 Safety of GLP-1 receptor agonist therapy in SID GLP-1 RAs and dual GIP/GLP-1 RAs are proven safe in T2DM ( The most significant concern regarding GLP-1 RAs therapy in patients receiving GCs is the potential for impaired absorption of medications due to slowed digestion and gastric emptying
Here is how to use them together for a complete, error-free protocol
The good news is that these medications are generally allowed into Japan for personal use , provided you follow a few important guidelines